6 March 2015
Results of AGM
IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.
About IXICO
IXICO, the brain health company, uses its innovative and proprietary digital platform technologies to help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes. Established since 2004, IXICO has significant experience in working with global pharmaceutical and biotechnology companies in dementia clinical studies and other neuro-degenerative disorders including Huntington's disease and Multiple Sclerosis.
More information is available on www.ixico.com
Enquiries:
IXICO plc
Derek Hill, CEO
Susan Lowther, CFO
Charles Spicer, VP Corporate Development
+44 20 3763 7499
Peel Hunt LLP (Nominated Adviser and Broker)
James Steel
Clare Terlouw
+44 20 7418 8900
Daniel Stewart & Company (Joint Broker)
Martin Lampshire
Mark Treharne
+44 207 776 6550
FTI Consulting Limited (Investor Relations)
Ben Atwell
Simon Conway
Matthew Moss
+44 20 3727 1000